Cart
sales@molnova.com
BMY 7378 dihydrochloride
CAS No. 21102-95-4
BMY 7378 dihydrochloride( —— )
Catalog No. M18235 CAS No. 21102-95-4
BMY-7378, α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 93 | In Stock |
|
| 200MG | 332 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMY 7378 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMY-7378, α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.
-
DescriptionBMY-7378, α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.
-
In VitroBMY 7378 is selective for the alpha 1D-adrenoceptor subtype (pKi: hamster alpha 1b-adrenoceptor 6.2, human alpha 1b-adrenoceptor 7.2; bovine alpha 1c-adrenoceptor 6.1, human alpha 1c-adrenoceptor 6.6; rat alpha 1d-adrenoceptor 8.2, human alpha 1d-adrenoceptor 9.4) and has high affinity (pA2, 8.9) for rat aorta alpha 1-adrenoceptor.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
Recptor5-HT1A| 5-HT1C| α1D-adrenoceptor| α2C-adrenoceptor| D2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number21102-95-4
-
Formula Weight458.42
-
Molecular FormulaC22H33Cl2N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cleary L, et al. Auton Autacoid Pharmacol. 2005 Oct;25(4):135-41.
molnova catalog
related products
-
Picein
Picein is derived from Picrorhiza kurroa and shows antioxidant properties.
-
Beta-Lapachone
Beta-Lapachone is a specific DNA topoisomerase I inhibitor, and no inhibitory activities against DNA topoisomerase II or ligase.
-
Atractylenolide II
Atractylenolide II has antimelanoma effect by inhibiting STAT3 signalling. Atractylenolide II has cytotoxic/apoptotic effects may via p38 activation , ERK and Akt inactivation, p53 dependent.
